SPONSOR
Hangzhou DAC Biotechnology Co., Ltd.
Total Trials
1
Recruiting
1
Phases
Phase 1
Hangzhou DAC Biotechnology Co., Ltd. is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Advanced Solid Tumors, Hematological Malignancies.
The trial portfolio spans Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Hangzhou DAC Biotechnology Co., Ltd.
How many clinical trials has Hangzhou DAC Biotechnology Co., Ltd. sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Hangzhou DAC Biotechnology Co., Ltd., of which 1 are actively recruiting participants. These trials cover conditions including Advanced Solid Tumors, Hematological Malignancies. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Hangzhou DAC Biotechnology Co., Ltd. research focus on?
Hangzhou DAC Biotechnology Co., Ltd. clinical trials span Advanced Solid Tumors, Hematological Malignancies. The research pipeline includes Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Hangzhou DAC Biotechnology Co., Ltd. clinical trial?
To participate in a Hangzhou DAC Biotechnology Co., Ltd. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Hangzhou DAC Biotechnology Co., Ltd. trials with current recruitment status updated daily.
Clinical Trials by Hangzhou DAC Biotechnology Co., Ltd.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology